212 related articles for article (PubMed ID: 11320555)
1. [Homocysteine--new risk factor for progression of atherosclerosis and its complications].
Brzósko S; Hryszko T; Małyszko J; Myśliwiec M
Pol Merkur Lekarski; 2001 Jan; 10(55):56-9. PubMed ID: 11320555
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin.
Perna AF; Castaldo P; Ingrosso D; De Santo NG
J Nephrol; 1999; 12(4):230-40. PubMed ID: 10493566
[TBL] [Abstract][Full Text] [Related]
3. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
[TBL] [Abstract][Full Text] [Related]
4. [Hyperhomocysteinemia and advancement of atherosclerosis in patients with chronic renal failure on maintenance hemodialysis].
Sydor A; Drozdz M; Kraśniak A; Miłkowski A; Chmiel G; Małczak J; Zabawa-Hołyś S; Moskal K; Podwysocki A; Szmigielski M; Czarnecka D; Gozdecka H; Kowalczyk-Michałek M; Szczeklik A; Wiecek A; Sułowicz W
Przegl Lek; 2002; 59(12):962-7. PubMed ID: 12731367
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia in end-stage renal failure.
Kes P
Acta Med Croatica; 2000; 54(4-5):175-81. PubMed ID: 11379482
[TBL] [Abstract][Full Text] [Related]
6. [Homocysteine. The cardiovascular risk factor of the next millennium?].
Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
[TBL] [Abstract][Full Text] [Related]
7. [Homocysteine--a risk factor for atherosclerosis].
Debreceni L
Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
[TBL] [Abstract][Full Text] [Related]
8. [Hyperhomocysteinaemia: physiopathology and medical implications].
Torre Delgadillo A; Téllez Zenteno JF; Morales Buenrrostro LE
Rev Invest Clin; 2000; 52(5):557-64. PubMed ID: 11195184
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
Wilson KM; Lentz SR
Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia in end stage renal disease: is treatment necessary?
Snavely J
Nephrol Nurs J; 2002 Apr; 29(2):155-60; quiz 161-2. PubMed ID: 11997950
[TBL] [Abstract][Full Text] [Related]
11. [Homocysteine and diabetes].
Januła A; Marek B; Kajdaniuk D; Sierek K; Borgiel-Marek H; Kos-Kudła B; Gatnar A; Gnot R; Strzyzewski A; Zeka G; Wyrwas-Bełz U
Wiad Lek; 2005; 58(5-6):319-23. PubMed ID: 16238125
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease.
Sainani GS; Sainani R
J Assoc Physicians India; 2002 May; 50 Suppl():16-23. PubMed ID: 12186151
[TBL] [Abstract][Full Text] [Related]
13. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
14. [Consequences of moderate hyperhomocysteinemia in internal medicine].
Zák A; Zeman M
Cas Lek Cesk; 2004; 143(6):367-74. PubMed ID: 15309862
[TBL] [Abstract][Full Text] [Related]
15. [Homocysteine and hyperhomocysteinemia].
Laskowska-Klita T
Pol Merkur Lekarski; 2001 Mar; 10(57):135-7. PubMed ID: 11398509
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia in renal diseases.
Ferechide D; Radulescu D
J Med Life; 2009; 2(1):53-9. PubMed ID: 20108491
[TBL] [Abstract][Full Text] [Related]
17. [Chronic complication of diabetes and homocysteine].
Idzior-Waluś B; Cieślik G
Przegl Lek; 2000; 57(12):732-5. PubMed ID: 11398598
[TBL] [Abstract][Full Text] [Related]
18. [Homocysteine metabolism and risk of cardiovascular diseases: importance of the nutritional status on folic acid, vitamins B6 and B12].
Alemán G; Tovar AR; Torres N
Rev Invest Clin; 2001; 53(2):141-51. PubMed ID: 11421110
[TBL] [Abstract][Full Text] [Related]
19. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.
De Caterina R; Zampolli A; Madonna R; Fioretti P; Vanuzzo D
Ital Heart J; 2004 Jun; 5 Suppl 6():19S-24S. PubMed ID: 15185912
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
